Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


29.07.2019

1 Am J Clin Oncol
1 Br J Cancer
1 Cancer Sci
2 Clin Lung Cancer
1 Eur J Cancer
1 J Comput Assist Tomogr
1 J Thorac Cardiovasc Surg
2 JAMA Oncol
1 Mol Cancer Ther
1 Oncologist
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. FATEHI HASSANABAD A, McBride SA
    Statins as Potential Therapeutics for Lung Cancer: Molecular Mechanisms and Clinical Outcomes.
    Am J Clin Oncol. 2019 Jul 19. doi: 10.1097/COC.0000000000000579.
    PubMed     Text format     Abstract available


    Br J Cancer

  2. GROEN HJM, van der Heijden EHFM, Klinkenberg TJ, Biesma B, et al
    Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study.
    Br J Cancer. 2019 Jul 24. pii: 10.1038/s41416-019-0533.
    PubMed     Text format     Abstract available


    Cancer Sci

  3. MIAO W, Sakai K, Sato H, Imamura R, et al
    Impaired ligand-dependent MET activation caused by an extracellularSEMA domain missense mutation in lung cancer.
    Cancer Sci. 2019 Jul 24. doi: 10.1111/cas.14142.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  4. WU JY, Yu CJ, Shih JY
    Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30169.
    PubMed     Text format     Abstract available

  5. SRIDHAR S, Paz-Ares L, Liu H, Shen K, et al
    Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30171.
    PubMed     Text format     Abstract available


    Eur J Cancer

  6. PASTORINO U, Sverzellati N, Sestini S, Silva M, et al
    Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
    Eur J Cancer. 2019;118:142-148.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  7. DIGUMARTHY SR, Shukla PK, Mendoza DP, Guo L, et al
    Postoperative Imaging After Lobectomy: Predicting the Displacement and Change in Orientation of Nonresected Lung Nodules.
    J Comput Assist Tomogr. 2019;43:592-598.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  8. ODELL DD, Feinglass J, Engelhardt K, Papastefan S, et al
    Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    J Thorac Cardiovasc Surg. 2019;157:1219-1235.
    PubMed     Text format     Abstract available


    JAMA Oncol

  9. TOPALIAN SL, Hodi FS, Brahmer JR, Gettinger SN, et al
    Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab.
    JAMA Oncol. 2019 Jul 25. pii: 2738775. doi: 10.1001/jamaoncol.2019.2187.
    PubMed     Text format     Abstract available

  10. KAZANDJIAN D, Gong Y, Keegan P, Pazdur R, et al
    Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.
    JAMA Oncol. 2019 Jul 25. pii: 2738768. doi: 10.1001/jamaoncol.2019.1747.
    PubMed     Text format     Abstract available


    Mol Cancer Ther

  11. XU K, Sun G, Li M, Chen H, et al
    Glibenclamide targets sulfonylurea receptor 1 to inhibit p70S6K activity and upregulate KLF4 expression to suppress non-small-cell lung carcinoma.
    Mol Cancer Ther. 2019 Jul 24. pii: 1535-7163.MCT-18-1181.
    PubMed     Text format     Abstract available


    Oncologist

  12. TAKAYAMA K, Ichiki M, Tokunaga S, Inoue K, et al
    Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer.
    Oncologist. 2019 Jul 22. pii: theoncologist.2019-0513.
    PubMed     Text format     Abstract available


    PLoS One

  13. GONZALEZ J, Henschke CI, Yankelevitz DF, Seijo LM, et al
    Emphysema phenotypes and lung cancer risk.
    PLoS One. 2019;14:e0219187.
    PubMed     Text format     Abstract available

  14. WEI T, Zhu D, Yang Y, Yuan G, et al
    The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
    PLoS One. 2019;14:e0219129.
    PubMed     Text format     Abstract available

  15. CAMERLINGO R, Miceli R, Marra L, Rea G, et al
    Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ss1 and miRNA21 cooperation.
    PLoS One. 2019;14:e0219597.
    PubMed     Text format     Abstract available

  16. TOPKAN E, Ozdemir Y, Kucuk A, Besen AA, et al
    Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients.
    PLoS One. 2019;14:e0218627.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: